STERIS PLC Reports 11.1% Year-Over-Year Increase in Total Revenue for Q1 FY2024

August 27, 2023

☀️Earnings Overview

STERIS PLC ($NYSE:STE) declared that its total revenue for the first quarter of FY2024 had grown to USD 1284.5 million, a 11.1% rise from the same period in the previous fiscal year, while its net income had increased by 11.0%, reaching USD 123.6 million, on June 30 2023.


GoodWhale has conducted a comprehensive analysis of STERIS PLC‘s fundamentals. Through its Risk Rating system, GoodWhale has determined that STERIS PLC is a medium risk investment in terms of financial and business aspects. GoodWhale has also detected two risk warnings in the company’s income sheet and balance sheet. To find out more about these risk warnings, users must become a registered user on GoodWhale’s website. Once registered, they can access this information and use it to make informed decisions about their investment in STERIS PLC. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Steris Plc. More…

    Total Revenues Net Income Net Margin
    5.09k 119.32 8.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Steris Plc. More…

    Operations Investing Financing
    806.33 -340.51 -570.94
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Steris Plc. More…

    Total Assets Total Liabilities Book Value Per Share
    10.78k 4.61k 61.6
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Steris Plc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    19.2% 13.5% 5.9%
    FCF Margin ROE ROA
    9.7% 3.1% 1.7%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    The company’s main competitors are Fonar Corp, Stryker Corp, and Dynatronics Corp.

    – Fonar Corp ($NASDAQ:FONR)

    Fonar Corporation is a holding company, which engages in the design, manufacture, sale, and service of magnetic resonance imaging (MRI) scanners. It operates through the following segments: Upright Multi-Position MRI; Stand-Up MRI; and Recurring Revenue. The Upright Multi-Position MRI segment designs, manufactures, and sells Upright Multi-Position MRI scanners. The Stand-Up MRI segment designs, manufactures, sells, and services Stand-Up MRI scanners. The Recurring Revenue segment provides service contracts, technical support, and parts sales. The company was founded by Stanley C. Krulick in 1978 and is headquartered in Melville, NY.

    – Stryker Corp ($NYSE:SYK)

    Stryker Corporation is one of the world’s leading medical technology companies. It offers a wide range of medical devices and services, including orthopedics, neurotechnology, and medical imaging. It has more than 87,000 employees worldwide.

    – Dynatronics Corp ($NASDAQ:DYNT)

    Dynatronics Corp is a medical device company that manufactures and markets physical therapy products and solutions. The company’s products are used by physical therapists, occupational therapists, athletic trainers, and other healthcare professionals. Dynatronics Corp has a market cap of 8.73M as of 2022, a Return on Equity of -10.7%. The company’s products are sold in the United States and internationally.


    STERIS PLC‘s first quarter of FY2024 was promising, as total revenue grew 11.1% from the same period last year to USD 1284.5 million. Net income similarly increased 11.0% year-over-year to USD 123.6 million. Investors should take note of the increasing sales and profitability of the company, suggesting that there may be potential for further growth. Considering the positive earnings report, investors should take into account the current market conditions to make an informed decision on whether to buy or sell shares of the company.

    Recent Posts

    Leave a Comment